Epithelioid sarcoma other diagnostic studies

Revision as of 20:15, 9 February 2016 by Ammu Susheela (talk | contribs)
Jump to navigation Jump to search

Epithelioid sarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Epithelioid sarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

MRI

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epithelioid sarcoma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epithelioid sarcoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epithelioid sarcoma other diagnostic studies

CDC on Epithelioid sarcoma other diagnostic studies

Epithelioid sarcoma other diagnostic studies in the news

Blogs on Epithelioid sarcoma other diagnostic studies

Directions to Hospitals Treating Epithelioid sarcoma

Risk calculators and risk factors for Epithelioid sarcoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Genetic Testing

  • Loss of INI1 (also known as hSNF5 and SMARCB1) which is a member of SWI/SNF multi subunit chromatin remodeling complex located on the long arm of chromosome 22 (22q11.2) has been a diagnostic modalty of epithelioid sarcoma.

Immunohistochemistry

  • Vimentin reactivity
  • Pankeratin AE1/AE3 and epithelial membrane antigen
  • Negative S100

Reference